 | Up a level |
Journal Article
Altay, L., Sitnilska, V., Schick, T., Widmer, G., Duchateau-Nguyen, G., Piraino, P., Jayagopal, A., Drawnel, F. M. and Fauser, S. (2019). Early local activation of complement in aqueous humour of patients with age-related macular degeneration. Eye, 33 (12). S. 1859 - 1865. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5454
Aslanidis, A., Karlstetter, M., Scholz, R., Fauser, S., Fried, C., Neumann, H., Pietsch, M. and Langmann, T. (2015). Activated Microglia/Macrophage Whey Acidic Protein (AMWAP) inhibits NF kappa B signaling and induces a neuroprotective phenotype in microglia. Glia, 63. S. E108 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1098-1136
Boon, C. J. F., van Dijk, E. H. C., Fauser, S., Breukink, M. D., Blanco-Garavito, R., Groenewoud, J. M. M., Keunen, J. E. E., Peters, P. J. H., Dijkman, G., Souied, E. H., MacLaren, R. E., Querques, G., Downes, S. M. and Hoyng, C. B. (2018). The PLACE trial: an open-label, multicenter, randomized controlled trial comparing half-dose photodynamic therapy with subthreshold micropulse laser for chronic central serous chorioretinopathy. Acta Ophthalmol., 96. S. 31 - 32. HOBOKEN: WILEY. ISSN 1755-3768
Buehler, A., Berger, S., Bengsch, F., Martin, G., Han, H., Vierkotten, S., Pielen, A., Boehringer, D., Schlunck, G., Fauser, S., Agostini, H. T., Reinheckel, T. and Stahl, A. (2013). Cathepsin proteases promote angiogenic sprouting and laser-induced choroidal neovascularisation in mice. Exp. Eye Res., 115. S. 73 - 79. LONDON: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD. ISSN 1096-0007
Chung, W. H., van Dijk, E. H. C., Mohabati, D., Dijkman, G., Yzer, S., de Jong, E. K., Fauser, S., Schlingemann, R. O., Hoyng, C. B. and Boon, C. J. F. (2017). Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome. Acta Ophthalmol., 95. S. 23 - 24. HOBOKEN: WILEY. ISSN 1755-3768
Enders, P., Schaub, F. and Fauser, S. (2018). Indications for Retinal Laser Therapy Revisited. Klinische Monatsblat. Augenheilkunde, 235 (12). S. 1383 - 1393. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3999
Enders, P., Scholz, P., Muether, P. S. and Fauser, S. (2016). Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration. Eye, 30 (8). S. 1072 - 1077. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5454
Ersoy, L., Schick, T., de Graft, D., Felsch, M., Hoyng, C. B., den Hollander, A. I., Kirchhof, B., Fauser, S. and Liakopoulos, S. (2016). Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes. Br. J. Ophthalmol., 100 (8). S. 1047 - 1052. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2079
Mohabati, D., van Dijk, E. H. C., van Rijssen, T. J., de Jong, E. K., Breukink, M. B., Martinez-Ciriano, J. P., Dijkman, G., Hoyng, C. B., Fauser, S., Yzer, S. and Boon, C. J. F. (2017). Severe phenotypes of chronic central serous chorioretinopathy: clinical characteristics and response to photodynamic therapy. Acta Ophthalmol., 95. S. 21 - 22. HOBOKEN: WILEY. ISSN 1755-3768
Rosentreter, A., Hoerster, R., Schick, T., Eter, N., Dietlein, T. S. and Fauser, S. (2015). Rebound tonometry after vitreoretinal surgery. Ophthalmologe, 112 (11). S. 917 - 923. NEW YORK: SPRINGER. ISSN 1433-0423
Schaub, F., Abdullatif, A. M. and Fauser, S. . Proliferative vitreoretinopathy prophylaxis Mission (im)possible. Ophthalmologe. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0423
Schaub, F., Enders, P. and Fauser, S. (2016). Proliferative Vitreoretinopathy: Therapeutic Strategies. Klinische Monatsblat. Augenheilkunde, 233 (9). S. 1016 - 1024. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3999
Schaub, F., Fauser, S., Kirchhof, B., Witte, A. and Hoerster, R. (2018). Laser flare photometry for identification of high-risk patients for proliferative vitreoretinopathy. Ophthalmologe, 115 (12). S. 1079 - 1084. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0423
Schellevis, R. L., van Dijk, E. H. C., van Bergen, M. G. J. M., Breukink, M. B., Altay, L., Scholz, P., Fauser, S., Meijer, O. C., Hoyng, C. B., den Hollander, A. I., Boon, C. J. F. and de Jong, E. K. (2017). A genetic variant in the NR3C2 gene, encoding the mineralocorticoid receptor, is associated with chronic central serous chorioretinopathy. Acta Ophthalmol., 95. S. 21 - 22. HOBOKEN: WILEY. ISSN 1755-3768
Schick, T., Steinhauer, M., Aslanidis, A., Altay, L., Karlstetter, M., Langmann, T., Kirschfink, M. and Fauser, S. (2017). Local complement activation in aqueous humor in patients with age-related macular degeneration. Eye, 31 (5). S. 810 - 814. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5454
Scholz, P., Altay, L. and Fauser, S. (2016). Comparison of subthreshold micropulse laser (577nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy. Eye, 30 (10). S. 1371 - 1378. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5454
Scholz, P., Altay, L. and Fauser, S. (2017). Response to 'Comment on 'Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy. Eye, 31 (2). S. 346 - 347. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5454
van Dijk, E. H. C., Hahn, L., van Rijssen, T. J., Scholz, P., Breukin, M. B., Souied, E. H., MacLaren, R. E., Querques, G., Fauser, S., Downes, S. M., Hoyng, C. B. and Boon, C. J. F. (2020). Pigment epithelial detachments in chronic central serous chorioretinopathy: Effect of half-dose photodynamic therapy versus high-density subthreshold micropulse laser PLACE trial report No. 5. Acta Ophthalmol., 98. S. 40 - 42. HOBOKEN: WILEY. ISSN 1755-3768
van de Ven, J. P. H., Nilsson, S. C., Tan, P. L., Buitendijk, G., Ristau, T., Mohlin, F. C., Nabuurs, S. B., Schoenmaker-Koller, F. E., Smailhodzic, D., Campochiarro, P. A., Zack, D. J., Duvvari, M. R., Bakker, B., Paun, C. C., Boon, C. J. F., Uitterlinden, A. G., Liakopoulos, S., Klevering, B. J., Fauser, S., Daha, M. R., Katsanis, N., Klaver, C. C. W., Blom, A. M., Hoyng, C. B. and den Hollander, A. I. (2013). A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Mol. Immunol., 56 (3). S. 247 - 249. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890